This site is intended for health professionals only

Home / News / Supply of epilepsy drug disrupted until May

Supply of epilepsy drug disrupted until May


By Beth Kennedy
Editor-in-chief

10 Jan 2020

The manufacturer Accord will be out of stock of the anti-epileptic drug Phenytoin Sodium NRIM 100mg capsules until ‘early May’.

The Department of Health and Social Care issued a supply disruption alert today (10 January), which contains advice on how to manage patients affected by the shortage.

The Pharmaceutical Services Negotiating Committee noted that as phenytoin is a category 1 anti-epileptic drug, it is recommended that patients are kept of a specific manufacturer’s product.

The negotiator noted that an alternative phenytoin sodium 100mg capsules manufactured by Flynn Pharma is available but warned that ‘switching to an alternative formulation requires monitoring and may also require specialist support, advice or referral’.


Want news like this straight to your inbox?


Latest News

welsh booster
Welsh pharmacies begin administering booster vaccines
Pharmacies in Wales have been commissioned to deliver Covid booster vaccines for the first time....
Health secretary calls for patients to go ‘directly to pharmacies’ instead of GPs
The health secretary, Sajid Javid, has said the Government is working on a minor ailments...
urgent care
CPCS pilot launching for referrals from urgent care settings
The Community Pharmacist Consultation Service (CPCS) has been extended in some areas of England to...